BACKGROUND: Colorectal cancer (CRC) can be prevented by the early detection and removal of advanced adenomas (AAs) by colonoscopy. Our aim was to evaluate peripheral blood leukocyte (PBL) telomere length as a potential biomarker for the presence of AAs. METHODS: PBL telomere length was measured in patients with AAs (n=35), in a control group of similarly aged patients who had a normal colonoscopy (n=145) and in a separate population group with no history of cancer, again similarly aged (n=495). Telomere measurements were performed using a quantitative PCR assay and reported as ratios of telomere and single copy gene measurements. RESULTS: Telomere lengths tended to be lower in patients with AAs than in patients in the normal colonoscopy group (p<0.001) as well as those in the population group (p=0.011). A telomere/single copy gene ratio of 0.5 was found to have an estimated 94% sensitivity and a 56% specificity for AAs; a combination of sensitivity and specificity for which a value of >0.5 would reduce the odds of a patient having AAs by a factor of 0.11 (the negative likelihood ratio). Thirty three percent of individuals in the population group tested above this cutoff and could be considered at low risk for AAs. CONCLUSIONS: PBL telomeres are shortened in patients with colorectal neoplasia, suggesting that PBL telomere length could be a promising non-invasive blood biomarker to pre-screen for risk of AAs prior to colonoscopy.
BACKGROUND:Colorectal cancer (CRC) can be prevented by the early detection and removal of advanced adenomas (AAs) by colonoscopy. Our aim was to evaluate peripheral blood leukocyte (PBL) telomere length as a potential biomarker for the presence of AAs. METHODS: PBL telomere length was measured in patients with AAs (n=35), in a control group of similarly aged patients who had a normal colonoscopy (n=145) and in a separate population group with no history of cancer, again similarly aged (n=495). Telomere measurements were performed using a quantitative PCR assay and reported as ratios of telomere and single copy gene measurements. RESULTS: Telomere lengths tended to be lower in patients with AAs than in patients in the normal colonoscopy group (p<0.001) as well as those in the population group (p=0.011). A telomere/single copy gene ratio of 0.5 was found to have an estimated 94% sensitivity and a 56% specificity for AAs; a combination of sensitivity and specificity for which a value of >0.5 would reduce the odds of a patient having AAs by a factor of 0.11 (the negative likelihood ratio). Thirty three percent of individuals in the population group tested above this cutoff and could be considered at low risk for AAs. CONCLUSIONS: PBL telomeres are shortened in patients with colorectal neoplasia, suggesting that PBL telomere length could be a promising non-invasive blood biomarker to pre-screen for risk of AAs prior to colonoscopy.
Authors: Robert Y L Zee; Amy J Castonguay; Nathaniel S Barton; Julie E Buring Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-08 Impact factor: 4.254
Authors: Robert A Smith; Vilma Cokkinides; Durado Brooks; Debbie Saslow; Otis W Brawley Journal: CA Cancer J Clin Date: 2010 Mar-Apr Impact factor: 508.702
Authors: I-Min Lee; Jennifer Lin; Amy J Castonguay; Nathaniel S Barton; Julie E Buring; Robert Y L Zee Journal: Clin Chem Lab Med Date: 2010-02 Impact factor: 3.694
Authors: Douglas J Robertson; Carol A Burke; H Gilbert Welch; Robert W Haile; Robert S Sandler; E Robert Greenberg; Dennis J Ahnen; Robert S Bresalier; Richard I Rothstein; Bernard Cole; Leila A Mott; John A Baron Journal: Ann Intern Med Date: 2009-07-21 Impact factor: 25.391
Authors: F A Oort; J S Terhaar Sive Droste; R W M Van Der Hulst; H A Van Heukelem; R J L F Loffeld; I C E Wesdorp; R L J Van Wanrooij; L De Baaij; E R Mutsaers; S van der Reijt; V M H Coupe; J Berkhof; A A Bouman; G A Meijer; C J J Mulder Journal: Aliment Pharmacol Ther Date: 2009-10-29 Impact factor: 8.171
Authors: Veryan Codd; Massimo Mangino; Pim van der Harst; Peter S Braund; Michael Kaiser; Alan J Beveridge; Suzanne Rafelt; Jasbir Moore; Chris Nelson; Nicole Soranzo; Guangju Zhai; Ana M Valdes; Hannah Blackburn; Irene Mateo Leach; Rudolf A de Boer; Masayuki Kimura; Abraham Aviv; Alison H Goodall; Willem Ouwehand; Dirk J van Veldhuisen; Wiek H van Gilst; Gerjan Navis; Paul R Burton; Martin D Tobin; Alistair S Hall; John R Thompson; Tim Spector; Nilesh J Samani Journal: Nat Genet Date: 2010-02-07 Impact factor: 38.330
Authors: Nirosha Suraweera; Dmitri Mouradov; Shan Li; Robert N Jorissen; Debbie Hampson; Anil Ghosh; Neel Sengupta; Mohamed Thaha; Shafi Ahmed; Michael Kirwan; Floor Aleva; David Propper; Roger M Feakins; Tom Vulliamy; Ngaire J Elwood; Pei Tian; Robyn L Ward; Nicholas J Hawkins; Zheng-Zhou Xu; Peter L Molloy; Ian T Jones; Matthew Croxford; Peter Gibbs; Andrew Silver; Oliver M Sieber Journal: Oncotarget Date: 2016-06-14
Authors: Rumana J Khan; Samson Y Gebreab; Pia R Crespo; Ruihua Xu; Amadou Gaye; Sharon K Davis Journal: Qual Life Res Date: 2017-06-08 Impact factor: 4.147
Authors: Brooke R Druliner; Xiaoyang Ruan; Ruth Johnson; Diane Grill; Daniel O'Brien; Tsung-Po Lai; Shahrooz Rashtak; Donna Felmlee-Devine; Jill Washechek-Aletto; Andrei Malykh; Thomas Smyrk; Ann Oberg; Hongfang Liu; Jerry W Shay; David A Ahlquist; Lisa A Boardman Journal: Clin Transl Gastroenterol Date: 2016-09-01 Impact factor: 4.488
Authors: Karl-Heinz Ladwig; Anne Catharina Brockhaus; Jens Baumert; Karoline Lukaschek; Rebecca T Emeny; Johannes Kruse; Veryan Codd; Sibylle Häfner; Eva Albrecht; Thomas Illig; Nilesh J Samani; H Erich Wichmann; Christian Gieger; Annette Peters Journal: PLoS One Date: 2013-07-03 Impact factor: 3.240